Literature DB >> 16415157

Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

Laura T Smith1, Mauting Lin, Romulo M Brena, James C Lang, David E Schuller, Gregory A Otterson, Carl D Morrison, Dominic J Smiraglia, Christoph Plass.   

Abstract

The identification of tumor suppressor genes has classically depended on their localization within recurrent regions of loss of heterozygosity. According to Knudson's two-hit hypothesis, the remaining allele is lost, either genetically or, more recently identified, through epigenetic events. To date, retrospective analyses have determined promoter methylation as a common alternative alteration in cancer cells to silence cancer-related genes. Here we report an application of restriction landmark genomic scanning that allows for DNA methylation profiling along a region of recurrent loss of heterozygosity at chromosome 6q23-q24. This approach resulted in the identification of a tumor suppressor gene, TCF21, which is frequently lost in human malignancies. We demonstrate that TCF21 is expressed in normal lung airway epithelial cells and aberrantly methylated and silenced in the majority of head and neck squamous cell carcinomas and non-small-cell lung cancers analyzed. TCF21 is known to regulate mesenchymal cell transition into epithelial cells, a property that has been shown to be deficient in carcinomas. We further demonstrate that exogenous expression of TCF21 in cells that have silenced the endogenous TCF21 locus resulted in a reduction of tumor properties in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415157      PMCID: PMC1348006          DOI: 10.1073/pnas.0510171102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  What defines a useful marker of metastasis in human cancer?

Authors:  D R Welch; C W Rinker-Schaeffer
Journal:  J Natl Cancer Inst       Date:  1999-08-18       Impact factor: 13.506

2.  Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population.

Authors:  Tu Ngoc Tran; Yenchun Liu; Minoru Takagi; Akira Yamaguchi; Hiroaki Fujii
Journal:  J Oral Pathol Med       Date:  2005-03       Impact factor: 4.253

3.  Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Authors:  Carla F Bender Kim; Erica L Jackson; Amber E Woolfenden; Sharon Lawrence; Imran Babar; Sinae Vogel; Denise Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

4.  Genomic alterations associated with malignancy in head and neck cancer.

Authors:  U Bockmühl; G Wolf; S Schmidt; A Schwendel; V Jahnke; M Dietel; I Petersen
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

5.  An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8).

Authors:  Y Okazaki; H Okuizumi; N Sasaki; T Ohsumi; J Kuromitsu; N Hirota; M Muramatsu; Y Hayashizaki
Journal:  Electrophoresis       Date:  1995-02       Impact factor: 3.535

Review 6.  Mouse models for human lung cancer.

Authors:  Ralph Meuwissen; Anton Berns
Journal:  Genes Dev       Date:  2005-03-15       Impact factor: 11.361

7.  Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs.

Authors:  J Lu; J A Richardson; E N Olson
Journal:  Mech Dev       Date:  1998-04       Impact factor: 1.882

Review 8.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Specificity of 6q- markers and other recurrent deviations in human malignant salivary gland tumors.

Authors:  J Sandros; J Mark; R P Happonen; G Stenman
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

10.  Partial 6q deletion in a human salivary gland adenocarcinoma.

Authors:  G Stenman; J Sandros; J Mark; S Edström
Journal:  Cancer Genet Cytogenet       Date:  1989-06
View more
  82 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

2.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

3.  Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.

Authors:  Z Yang; D M Li; Q Xie; D Q Dai
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

4.  Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Khelifa Arab; Rosemary E Teresi; Yasuhiro Tada; Charis Eng; Christoph Plass
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

5.  Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer.

Authors:  Baokun Chen; Chao Zeng; Yiwang Ye; Da Wu; Zhimin Mu; Jixian Liu; Yuancai Xie; Hao Wu
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

6.  Epigenetic regulation of beta2-adrenergic receptor expression in T(H)1 and T(H)2 cells.

Authors:  Jaclyn W McAlees; Laura T Smith; Robert S Erbe; David Jarjoura; Nicholas M Ponzio; Virginia M Sanders
Journal:  Brain Behav Immun       Date:  2010-11-01       Impact factor: 7.217

7.  Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Authors:  Narayan Shivapurkar; Victor Stastny; Naoki Okumura; Luc Girard; Yang Xie; Clemens Prinsen; Frederik B Thunnissen; Ignacio I Wistuba; Bogdan Czerniak; Eugene Frenkel; Jack A Roth; Triantafillos Liloglou; George Xinarianos; John K Field; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

8.  Clinicopathological significance and biological role of TCF21 mRNA in breast cancer.

Authors:  Jie Wang; Xueren Gao; Mingxi Wang; Jianqiong Zhang
Journal:  Tumour Biol       Date:  2015-06-06

9.  The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

Authors:  S Kalari; M Jung; K H Kernstine; T Takahashi; G P Pfeifer
Journal:  Oncogene       Date:  2012-08-20       Impact factor: 9.867

10.  Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.

Authors:  Daniel Weiss; Christian Stockmann; Katrin Schrödter; Claudia Rudack
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.